154 related articles for article (PubMed ID: 8748888)
1. Intravital capillaroscopy in patients with chronic venous insufficiency and lymphoedema: relevance to Daflon 500 mg.
Bollinger A; Herrig I; Fischer M; Hoffmann U; Franzeck UK
Int J Microcirc Clin Exp; 1995; 15 Suppl 1():41-4. PubMed ID: 8748888
[TBL] [Abstract][Full Text] [Related]
2. Microangiopathy of cutaneous blood and lymphatic capillaries in chronic venous insufficiency (CVI).
Franzeck UK; Haselbach P; Speiser D; Bollinger A
Yale J Biol Med; 1993; 66(1):37-46. PubMed ID: 8256463
[TBL] [Abstract][Full Text] [Related]
3. An original microhaemorheological approach to the pharmacological effects of Daflon 500 mg in severe chronic venous insufficiency.
Allegra C; Bartolo M; Carioti B; Cassiani D
Int J Microcirc Clin Exp; 1995; 15 Suppl 1():50-4. PubMed ID: 8748890
[TBL] [Abstract][Full Text] [Related]
4. Laser Doppler and transcutaneous oximetry: modern investigations to assess drug efficacy in chronic venous insufficiency.
Belcaro G; Cesarone MR; de Sanctis MT; Incandela L; Laurora G; Février B; Wargon C; De Gregoris P
Int J Microcirc Clin Exp; 1995; 15 Suppl 1():45-9. PubMed ID: 8748889
[TBL] [Abstract][Full Text] [Related]
5. [Microangiopathies in chronic venous insufficiency (CVI)].
Leu AJ; Franzeck UK; Bollinger A
Ther Umsch; 1991 Oct; 48(10):715-21. PubMed ID: 1780801
[TBL] [Abstract][Full Text] [Related]
6. Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders.
Struckmann JR; Nicolaides AN
Angiology; 1994 Jun; 45(6):419-28. PubMed ID: 8203767
[TBL] [Abstract][Full Text] [Related]
7. [Significance of cutaneous microangiopathy for the pathogenesis of dermatitis in venous congestion due to chronic venous insufficiency].
Jünger M; Hahn U; Bort S; Klyscz T; Hahn M; Rassner G
Wien Med Wochenschr; 1994; 144(10-11):206-10. PubMed ID: 7856186
[TBL] [Abstract][Full Text] [Related]
8. Microvascular changes in chronic venous insufficiency--a review.
Leu AJ; Leu HJ; Franzeck UK; Bollinger A
Cardiovasc Surg; 1995 Jun; 3(3):237-45. PubMed ID: 7655836
[TBL] [Abstract][Full Text] [Related]
9. Controlled studies of Daflon 500 mg in chronic venous insufficiency.
Geroulakos G; Nicolaides AN
Angiology; 1994 Jun; 45(6 Pt 2):549-53. PubMed ID: 8203786
[TBL] [Abstract][Full Text] [Related]
10. Techniques used to evaluate the cutaneous microcirculation: application of photoplethysmography to the assessment of a phlebotropic agent in the treatment of leg ulcers.
Guillot B
Angiology; 1994 Jun; 45(6 Pt 2):542-8. PubMed ID: 8203785
[TBL] [Abstract][Full Text] [Related]
11. Microangiopathy in mild chronic venous incompetence (CVI): morphological alterations and increased transcapillary diffusion detected by fluorescence videomicroscopy.
Speiser DE; Bollinger A
Int J Microcirc Clin Exp; 1991 Feb; 10(1):55-66. PubMed ID: 2019484
[TBL] [Abstract][Full Text] [Related]
12. At the Crossroads of Venous Insufficiency and Hemorrhoidal Disease: Daflon 500 mg. Proceedings of a symposium. Vienna, Austria, January 31, 1992.
Angiology; 1994 Jun; 45(6 Pt 2):493-584. PubMed ID: 7911285
[No Abstract] [Full Text] [Related]
13. Microcirculatory dysfunction in chronic venous insufficiency (CVI).
Jünger M; Steins A; Hahn M; Häfner HM
Microcirculation; 2000; 7(6 Pt 2):S3-12. PubMed ID: 11151969
[TBL] [Abstract][Full Text] [Related]
14. Microvascular changes in venous disease: an update.
Bollinger A; Leu AJ; Hoffmann U; Franzeck UK
Angiology; 1997 Jan; 48(1):27-32. PubMed ID: 8995340
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic potential of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin in treatment chronic venous disorder].
Hnátek L
Vnitr Lek; 2015 Sep; 61(9):807-14. PubMed ID: 26465280
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous microcirculation in skin lesions associated with chronic venous insufficiency.
Stücker M; Schöbe MC; Hoffmann K; Schultz-Ehrenburg U
Dermatol Surg; 1995 Oct; 21(10):877-82. PubMed ID: 7551745
[TBL] [Abstract][Full Text] [Related]
17. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study.
Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Di Renzo A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M
Angiology; 2005; 56(1):1-8. PubMed ID: 15678250
[TBL] [Abstract][Full Text] [Related]
18. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
Amato C
Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic approach to chronic venous insufficiency and its complications: place of Daflon 500 mg.
Bergan JJ; Schmid-Schönbein GW; Takase S
Angiology; 2001 Aug; 52 Suppl 1():S43-7. PubMed ID: 11510596
[TBL] [Abstract][Full Text] [Related]
20. [Microangiopathy in chronic venous insufficiency].
Leu AJ; Yanar A; Pfister G; Geiger M; Franzeck UK; Bollinger A
Dtsch Med Wochenschr; 1991 Mar; 116(12):447-53. PubMed ID: 2004586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
